Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's been deleted again at the site you cite. (no pun intended).
I am not so sure. The DCs of patient A recognize the tumor as foreign and therefore set them up for attack by the T cells, would they also not recognize patient B's normal cells (not just tumor cells) and set them up for T cell attack in patient A to whom these are all foreign cells.?
Like I said in my earlier post, I hope you are right. But no debate proves nothing, as I pointed out from the article I cited to. It almost always happens. I too hope that eventually this bill is passed.
I hope you are right, but this does not prove anything. Here is a quote from the Wiki cited by Flipper in an earlier post.
You are way underestimating!!
Yup, It is no coincidence that they released the NWBO press release on Dec 21, 2023 that "YESTERDAY" they had submitted for approval, ie., on Dec.20, 2023 thus making the cut for the Dec 25, 2023 with a few days to spare in order to qualify for the March 21-21, 2024 CHM meeting dates. Perfect scheduling. SEE NWBIO PR at https://nwbio.com/northwest-biotherapeutics-announces-marketing-authorization-applications-submitted-uk-mhra-dcvax-l-glioblastoma/
I am wondering, now that the Court has given Posner leave to refile the case for 30 days, will she take this opportunity to add more instances of spoofing to this case that the defendants had the brazen temerity to continue to do since the last filing of the case, even while the watchful eyes of the court (and the rest of the world) were upon them.
Is it 25 M shares or options? Btw it is Navid - not David
That's Navid Malik PhD, MBA, Independent Director
Not
Please define what is the line (of total holdings) that demarks between Large investors and small investors for you so we have a little more clarity in what you are talking about.
I kicked myself as well for passing up that one. I was going to buy some but then chickened out. It just wasn't to be. I think I got it right this time, but it has been much longer than I ever expected.
Thanx for this.
Here is a quote from this paper:
207 Liau, L. M. et al. Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 prospective externally controlled cohort trial. JAMA Oncol. 9, 112 (2023).
208 Liau, L. M. et al. First results on survival from a large phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. J. Transl. Med. 16, 142 (2018).
sounds to me like he is shooting from the hip on those numbers. IMHO that is way too low. Where did he dream up those numbers?
You're spouting a bunch of crap.
Meirluc, I am a long and agree with your prognosis for a very positive future for NWBO. My point was that Pfizer chose to go for a bird in hand rather than risk of purchasing great future potential without any current regulator approval.
Your case is all about the future: "Within the next 3-5 years ..." and "will be introduced ..." and "will also be reflected ..." and "is going to be the next major treatment ..." and "will likely improve."
Bottom line, I agree with your FUTURE expectations, but we are not discussing the future, just the fact that Pfizer chose to buy a bird ALREADY in hand, not withstanding the greater future potential for NWBO.
Yes, I did not notice that, I took your post as a response to my last post, not a previous one - my bad.
You changed the subject. We were not discussing "who wins" but why Pfizer chose Seagen rather than NWBO. You refuse to admit the obvious.
Flip, I agree with all that you say on this. All true IMHO. But you have to grant me this, that as good as the future may be for NWBO, it is all still truly potential yet to be proven by actual regulatory approval where it counts - not yet a bird in hand.
I do not know much about the Pfizer-Seagen take over, but I Googled a little information. Even from the little I learned, the comparison is not really fair. It is comparing NWBO to Seagen as though they are quite similar. They are not.
Basically you are comparing great potential in the case of NWBO to the current actual accomplished reality. Here is the basic comparison just prior to closing as I see it.
1. Current revenue: Seagen -Almost $2 Bil per year VS. NWBO - nearly NIL
2, Current approved drugs: Seagen - 4 VS NWBO - None
3. Outstanding shares: Seagen - about 200,000,000 VS NWB) about 1.7 Billion shares fully diluted
4. Potential a decade from now: Seagen - Bought out for growth of actual abilities to better future potential VS NWBO - GREAT revolutionary potential for ALL cancers but yet to be proven and actualized.
Pfizer wanted a bird in hand and bought it, rather than two or more birds in the woods that it still had to catch.
A simple common sense approach seems to be - given that Linda Powers will not sell to BP on the cheap and wants full value, the choice left for BP is buy high now or buy high later, the answer is obvious - buy high later. So for now no BO on the horizon until more news.
Some say that he was banned?? Why on earth?? How does banning work on iHub? How many moderators does it take to ban someone? How many bashers are now moderators and who appoints them??? Is this true?
I would guess that he is working on digesting the Jan 26 responses of both the plaintiff and the defense and putting in a form the lay people can understand along with his comments. Perhaps we will see that tomorrow.
Or they are back under a new pen name.
thanx for that.
Thanks for that. Very useful. I will not leave iHub, but be less attached in the future. I nit-pik, the dating of the posts is not as clear or as easy to follow as on iHub
Hi Hoff,
Where are the alternate boards or websites that NWBO longs are migrating to? I might like to check them out. Can you provide a few links. I am getting tired of skipping over the bashers' posts. (I do not block anyone, just skip their posts).
It is not in the hands of Judge Woods quite yet. The parties still have until Jan 26 to respond to the other sides objections then after the 26th it will will be in the hands of Woods for his decision on the MTD and if necessary the leave to file an amended complaint.
Whatever pennies they are paying you, is way more than you are worth.
They probably think it will be cheaper to buy or partner (at the right time) rather than rediscover what NWBO already knows after many years (and free of patent challenges valid or not that could be costly).
I suspect, they are plenty interested, but the price tag probably set by LP is too high (for now).
I believe that in the Posner response there is a request to the Court, should they decide to grant MTD, that the Court also give plaintiff leave to file another amended complaint to perfect the case against a future MTD.
What level of confidence do you have at this time that the Judge will deny the MTD. Of course that may change somewhat after you have seen both of the responses after Jan 26. In any case even if the Judge does grant the MTD, what is the chance in your opinion that he will grant Posner the opportunity to again amend the complaint as Posner requested?